Matinas BioPharma Holdings

Matinas BioPharma Holdingshttps://investorshangout.com/Matinas-BioPharma-Holdings-MTNB-90550/en-usSun, 13 Sep 2026 14:19:29 GMTCopyright InvestorsHangout.comwhytestocks: $MTNB News Article - Why Is Inflammatory Focused Matinas BioPharma Stock Trading Higher Today? | Benhttps://investorshangout.com/post/view?id=6657486https://investorshangout.com/post/view?id=6657486Wed, 27 Dec 2023 16:15:46 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvemhttps://investorshangout.com/post/view?id=6657367https://investorshangout.com/post/view?id=6657367Wed, 27 Dec 2023 13:00:45 GMTznewcar1: $MTNB 27% v17,7M c.32 f217,264M Hod.32 ML.125 RL.2037 PMH.37https://investorshangout.com/post/view?id=6641827https://investorshangout.com/post/view?id=6641827Wed, 08 Nov 2023 02:43:38 GMTwhytestocks: $MTNB News Article - Penny Stocks To Buy Now? 3 to Watch With Big News https://investorshangout.com/post/view?id=6641576https://investorshangout.com/post/view?id=6641576Tue, 07 Nov 2023 15:30:57 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Positive in vivo Efficacy Results of Oral LNC Docethttps://investorshangout.com/post/view?id=6641570https://investorshangout.com/post/view?id=6641570Tue, 07 Nov 2023 15:25:53 GMTznewcar1: $MTNB 313% v368,9M C.641 f217,264M Hod.89 ML.1172 LL.1103https://investorshangout.com/post/view?id=6630758https://investorshangout.com/post/view?id=6630758Wed, 11 Oct 2023 22:37:13 GMTwhytestocks: $MTNB News Article - 24/7 Market News Lunch Break 11 Oct 2023 https://investorshangout.com/post/view?id=6630601https://investorshangout.com/post/view?id=6630601Wed, 11 Oct 2023 16:20:47 GMTwhytestocks: $MTNB News Article - Biotech Catches Massive Premarket Bid https://investorshangout.com/post/view?id=6630507https://investorshangout.com/post/view?id=6630507Wed, 11 Oct 2023 14:15:47 GMTwhytestocks: $MTNB News Article - Patient with Candida krusei Infection in Matinas BioPharma's Oral MAT2203 Expanhttps://investorshangout.com/post/view?id=6630409https://investorshangout.com/post/view?id=6630409Wed, 11 Oct 2023 12:00:47 GMTthe lawman: Matinas deserves congratulations for getting publication of the ENACT trial results in a peer reviewhttps://investorshangout.com/post/view?id=6611147https://investorshangout.com/post/view?id=6611147Tue, 22 Aug 2023 22:07:48 GMTwhytestocks: $MTNB News Article - Compassionate Use Patient Treated with Matinas BioPharma's MAT2203 and Showing https://investorshangout.com/post/view?id=6562772https://investorshangout.com/post/view?id=6562772Tue, 18 Apr 2023 15:25:48 GMTthe lawman: Following is a comment I posted today on Biontech's website: I am writing to you as a shareholderhttps://investorshangout.com/post/view?id=6491047https://investorshangout.com/post/view?id=6491047Fri, 28 Oct 2022 21:16:55 GMTthe lawman: It has been over six months since BNTX paid almost $4 million for the exclusive rights to do a deal https://investorshangout.com/post/view?id=6489970https://investorshangout.com/post/view?id=6489970Wed, 26 Oct 2022 21:21:50 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Positive Interim Data from the Phase 2 EnACT Trial https://investorshangout.com/post/view?id=6488161https://investorshangout.com/post/view?id=6488161Fri, 21 Oct 2022 14:35:52 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Shttps://investorshangout.com/post/view?id=6487219https://investorshangout.com/post/view?id=6487219Wed, 19 Oct 2022 20:50:52 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Chairman Succession Plan https://investorshangout.com/post/view?id=6474120https://investorshangout.com/post/view?id=6474120Wed, 21 Sep 2022 17:10:52 GMTthe lawman: If BNTX and MTNB were to collaborate, the combination would be formidable. BNTX, with its MRNA technhttps://investorshangout.com/post/view?id=6445168https://investorshangout.com/post/view?id=6445168Thu, 28 Jul 2022 19:55:58 GMTxxxSchlingelxxx: I created a new private MTNB Board here on Investors Hangout. I want to try to bring serious discusshttps://investorshangout.com/post/view?id=6424103https://investorshangout.com/post/view?id=6424103Sat, 18 Jun 2022 11:52:55 GMTwhytestocks: $MTNB News Article - Matinas BioPharma to Present at the LD Micro Invitational XII Conference https://investorshangout.com/post/view?id=6412934https://investorshangout.com/post/view?id=6412934Tue, 31 May 2022 17:51:04 GMTznewcar1: MTNB 23% v4,7M c.9575 f216M H.9851https://investorshangout.com/post/view?id=6381463https://investorshangout.com/post/view?id=6381463Mon, 11 Apr 2022 20:15:01 GMTwhytestocks: $MTNB News Article - Matinas BioPharma to Participate in the 2022 Virtual Growth Conference Presentehttps://investorshangout.com/post/view?id=6368145https://investorshangout.com/post/view?id=6368145Tue, 22 Mar 2022 20:25:58 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results ahttps://investorshangout.com/post/view?id=6358086https://investorshangout.com/post/view?id=6358086Tue, 08 Mar 2022 15:55:48 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Fourth andhttps://investorshangout.com/post/view?id=6302881https://investorshangout.com/post/view?id=6302881Thu, 16 Dec 2021 13:06:06 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer https://investorshangout.com/post/view?id=6295661https://investorshangout.com/post/view?id=6295661Mon, 06 Dec 2021 19:10:49 GMTthe lawman: Gilead announced results from a double-blind Phase 3 clinical trial which showed that early administhttps://investorshangout.com/post/view?id=6246393https://investorshangout.com/post/view?id=6246393Wed, 22 Sep 2021 16:51:56 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Accomplished Biotechnology Executive and Drug Develhttps://investorshangout.com/post/view?id=6243996https://investorshangout.com/post/view?id=6243996Mon, 20 Sep 2021 12:05:52 GMTznewcar1: MTNB 27% v12,6M c1.05 f214M H1.1https://investorshangout.com/post/view?id=6239223https://investorshangout.com/post/view?id=6239223Mon, 13 Sep 2021 20:13:39 GMTthe lawman: The results announced today, for the LNC version of amphotericin b, are for a trial sponsored and fuhttps://investorshangout.com/post/view?id=6238938https://investorshangout.com/post/view?id=6238938Mon, 13 Sep 2021 16:50:15 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Issuance of U.S. Patent Protecting MAT2203 to Treathttps://investorshangout.com/post/view?id=6215779https://investorshangout.com/post/view?id=6215779Mon, 16 Aug 2021 15:50:48 GMTthe lawman: The NIH, headed by Fauci, asked MTNB to create a safe, oral version of Remdesivir, which it has beenhttps://investorshangout.com/post/view?id=6206263https://investorshangout.com/post/view?id=6206263Wed, 04 Aug 2021 22:23:44 GMTthe lawman: Perhaps it's just me, but I will take the word of Dr. Kastelein, perhaps the world's foremost authorhttps://investorshangout.com/post/view?id=6037707https://investorshangout.com/post/view?id=6037707Tue, 02 Feb 2021 00:08:01 GMTthe lawman: Lypdiso is the brand name for MAT 9001, that is now in a second head to head trial vs. Vascepa, withhttps://investorshangout.com/post/view?id=6014778https://investorshangout.com/post/view?id=6014778Mon, 11 Jan 2021 16:57:29 GMTznewcar1: MTNB 27% v20,7M c1.74 f199M H1.82https://investorshangout.com/post/view?id=6007654https://investorshangout.com/post/view?id=6007654Mon, 04 Jan 2021 22:03:57 GMTznewcar1: MTNB 32% v32,2M c1.47 f199M H1.48https://investorshangout.com/post/view?id=6004376https://investorshangout.com/post/view?id=6004376Thu, 31 Dec 2020 02:13:48 GMTwhytestocks: $MTNB News Article - Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch https://investorshangout.com/post/view?id=6003678https://investorshangout.com/post/view?id=6003678Wed, 30 Dec 2020 15:15:46 GMTznewcar1: MTNB 26% v19,3M c1.11 f199M H1.15 S1.03https://investorshangout.com/post/view?id=6003090https://investorshangout.com/post/view?id=6003090Tue, 29 Dec 2020 21:31:09 GMTthe lawman: $4 price target by BTIG's 5 star analyst, Robert Hazlett, helps, but it is old news. What is morhttps://investorshangout.com/post/view?id=6002860https://investorshangout.com/post/view?id=6002860Tue, 29 Dec 2020 18:23:47 GMTthe lawman: Short term catalysts abound from top line results for the MAT 9001's second head to head trial vs. Vhttps://investorshangout.com/post/view?id=6001600https://investorshangout.com/post/view?id=6001600Mon, 28 Dec 2020 17:07:33 GMTthe lawman: Results from the second head to head trial of MAT 9001 vs Vascepa will be announced in 1Q 2021. If, https://investorshangout.com/post/view?id=6000269https://investorshangout.com/post/view?id=6000269Thu, 24 Dec 2020 21:53:12 GMTthe lawman: Correction to last post: Whatever the reason for the EOY drop, catalysts abound in the coming 6 mhttps://investorshangout.com/post/view?id=5999646https://investorshangout.com/post/view?id=5999646Wed, 23 Dec 2020 22:02:21 GMTthe lawman: Whatever the reason for the EOY drop, catalysts abound in the coming 6 months including topline resuhttps://investorshangout.com/post/view?id=5999634https://investorshangout.com/post/view?id=5999634Wed, 23 Dec 2020 21:44:13 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Files Preliminary Proxy for Special Meeting of Stockholders https://investorshangout.com/post/view?id=5982577https://investorshangout.com/post/view?id=5982577Mon, 07 Dec 2020 16:30:48 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Positive End of Phase 2 Meeting with the FDA for MAhttps://investorshangout.com/post/view?id=5894265https://investorshangout.com/post/view?id=5894265Tue, 15 Sep 2020 14:35:52 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Publication of Results from Phase 1 Portion of the https://investorshangout.com/post/view?id=5867112https://investorshangout.com/post/view?id=5867112Thu, 20 Aug 2020 14:40:47 GMTznewcar1: MTNB 32% v3,2M c.760 f196,5M H.78 gap up S@.61 followed VWAP for a while and had a false BO.65 oncehttps://investorshangout.com/post/view?id=5733614https://investorshangout.com/post/view?id=5733614Tue, 14 Apr 2020 01:05:45 GMTwhytestocks: $MTNB News Article - Matinas BioPharma Announces Closing of Public Offering of Common Stock https://investorshangout.com/post/view?id=5642984https://investorshangout.com/post/view?id=5642984Tue, 14 Jan 2020 16:35:42 GMTznewcar1: MTNB 23% v7,6M c1.92 f162M H 1.96 EOD push. small gap up then shot over 1.6-1.7 then back https://investorshangout.com/post/view?id=5612027https://investorshangout.com/post/view?id=5612027Fri, 06 Dec 2019 21:56:57 GMTznewcar1: MTNB 19% v11M c1.24 f162M H1.4099 S1.2https://investorshangout.com/post/view?id=5595612https://investorshangout.com/post/view?id=5595612Tue, 19 Nov 2019 04:21:12 GMTwhytestocks: $MTNB News Article - Top Penny Stocks to Buy Or Avoid Amid Growing Optimism https://investorshangout.com/post/view?id=5595293https://investorshangout.com/post/view?id=5595293Mon, 18 Nov 2019 19:50:45 GMTwhytestocks: $MTNB News Article - Matinas BioPharma to Present at the 31st Annual Piper Jaffray Healthcare Conferhttps://investorshangout.com/post/view?id=5594687https://investorshangout.com/post/view?id=5594687Mon, 18 Nov 2019 13:05:41 GMT